These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15611443)

  • 1. Successful treatment of recalcitrant, erythroderma-associated pruritus with etanercept.
    Querfeld C; Guitart J; Kuzel TM; Rosen S
    Arch Dermatol; 2004 Dec; 140(12):1539-40. PubMed ID: 15611443
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of etanercept in treating pruritus and preventing new lesions in Grover disease.
    Norman R; Chau V
    J Am Acad Dermatol; 2011 Apr; 64(4):796-8. PubMed ID: 21414507
    [No Abstract]   [Full Text] [Related]  

  • 3. [Psoriatic erythroderma treated with etanercept].
    Piqué-Duran E; Pérez-Cejudo JA
    Actas Dermosifiliogr; 2007 Sep; 98(7):508-10. PubMed ID: 17669311
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating the tolerability and efficacy of etanercept compared to triamcinolone acetonide for the intralesional treatment of keloids.
    Berman B; Patel JK; Perez OA; Viera MH; Amini S; Block S; Zell D; Tadicherla S; Villa A; Ramirez C; De Araujo T
    J Drugs Dermatol; 2008 Aug; 7(8):757-61. PubMed ID: 18720692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
    Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A
    Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of recalcitrant pemphigus vulgaris and pemphigus vegetans with etanercept and carbon dioxide laser.
    Lin MH; Hsu CK; Lee JY
    Arch Dermatol; 2005 Jun; 141(6):680-2. PubMed ID: 15967912
    [No Abstract]   [Full Text] [Related]  

  • 7. Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience.
    Antoniou C; Dessinioti C; Stratigos A; Avgerinou G; Stavropoulos P; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):979-82. PubMed ID: 19470056
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of pemphigus vulgaris with etanercept in four patients.
    Shetty A; Marcum CB; Glass LF; Carter JD
    J Drugs Dermatol; 2009 Oct; 8(10):940-3. PubMed ID: 19852124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis.
    Safa G; Loppin M; Bousser AM; Barbarot S
    J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S19-20. PubMed ID: 17097376
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and efficacy study on etanercept in patients with plaque psoriasis.
    Costanzo A; Mazzotta A; Papoutsaki M; Nisticò S; Chimenti S
    Br J Dermatol; 2005 Jan; 152(1):187-9. PubMed ID: 15656833
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of etanercept therapy in disseminated granuloma annulare.
    Kreuter A; Altmeyer P; Gambichler T
    Arch Dermatol; 2006 Sep; 142(9):1236-7; author reply 1237. PubMed ID: 16983020
    [No Abstract]   [Full Text] [Related]  

  • 12. Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
    Juan A; Ribas B; Nadal C; Ros I
    J Rheumatol; 2005 Oct; 32(10):2061; author reply 2061-2. PubMed ID: 16206372
    [No Abstract]   [Full Text] [Related]  

  • 13. Etanercept for the treatment of hidradenitis suppurativa.
    Sotiriou E; Apalla Z; Ioannidos D
    Acta Derm Venereol; 2009; 89(1):82-3. PubMed ID: 19197548
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful use of etanercept in type I pityriasis rubra pilaris.
    Seckin D; Tula E; Ergun T
    Br J Dermatol; 2008 Mar; 158(3):642-4. PubMed ID: 18081896
    [No Abstract]   [Full Text] [Related]  

  • 15. Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept.
    Kuek A; Weerakoon A; Ahmed K; Ostör AJ
    Rheumatology (Oxford); 2007 Jun; 46(6):1043-4. PubMed ID: 17449487
    [No Abstract]   [Full Text] [Related]  

  • 16. When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis.
    Prince FH; Twilt M; Simon SC; van Rossum MA; Armbrust W; Hoppenreijs EP; Kamphuis S; van Santen-Hoeufft M; Koopman-Keemink Y; Wulffraat NM; ten Cate R; van Suijlekom-Smit LW
    Ann Rheum Dis; 2009 Jul; 68(7):1228-9. PubMed ID: 19525408
    [No Abstract]   [Full Text] [Related]  

  • 17. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
    Spadaro A; Ceccarelli F; Scrivo R; Valesini G
    Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
    [No Abstract]   [Full Text] [Related]  

  • 18. Acrodermatitis continua resistant to etanercept: therapeutic challenge and unfortunate outcome.
    Gokdemir G; Kutlu S; Köşlü A
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):345-7. PubMed ID: 18554224
    [No Abstract]   [Full Text] [Related]  

  • 19. Two years of experience with etanercept in recalcitrant psoriasis.
    Ahmad K; Rogers S
    Br J Dermatol; 2007 May; 156(5):1010-4. PubMed ID: 17408393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A; Perez VL; Hammel JP; Lowder CY
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.